CARLSBAD, Calif., Dec. 10, 2014 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSX-V:ASG) announced today that it will be participating at the 2014 DWG (Deutscher Wirbelsäulenkongress) Trade Show Conference from Thursday, December 11th to Saturday, December 13th in the "Congress Center Leipzig", Leipzig, Germany.
"Aurora Spine is please to exhibit this year at the German Spine Society in Leipzig, Germany," said Sven Claes, Aurora Spine's International Product Director. "We will display our complete range of minimally invasive spine implants, including the ZIP(TM) MIS Interspinous Fusion systems, as well as our Interbody portfolio featuring TiNano®. TiNano is Aurora Spine's titanium plasma spray coating on PEEK-OPTIMA interbody cages allowing for the possibility of bone ongrowth due to its porous structure. Also on display will be our brand new Sentio MMG® neuromonitoring system. Unlike traditional EMG systems, SENTIO works without needles, is surgeon controlled, and does not require a technician in the operating room. Come and visit us at booth #87 for a demonstration."
DWG will include the latest advancements and technologies related to spine technology and scientific achievements in the field of spine to neurosurgeons, orthopedic surgeons and scientists.
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine recently obtained its 5th FDA clearance in the past 11 months and continues to position itself at the forefront of spinal surgery procedures, focusing on minimally invasive spine surgery technologies. Aurora Spine is changing spine surgery by focusing on disruptive technologies following the Company's commitment to - Simplifying the Complex.
Forward-Looking Statements
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the growth potential of Aurora Spine's products. Aurora Spine cautions investors of its securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
For more information, please contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Eric Fronk
Chief Financial Officer
(760) 424-2004
HUG#1878720